Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Marija Polovina, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 5, pp. 553-576
Open Access | Times Cited: 316

Showing 1-25 of 316 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8765
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Katja Zeppenfeld, Jacob Tfelt‐Hansen, Marta Riva, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3997-4126
Closed Access | Times Cited: 1691
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1508
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Heart Journal (2019) Vol. 40, Iss. 40, pp. 3297-3317
Open Access | Times Cited: 1322
2023 ESC Guidelines for the management of cardiomyopathies
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3503-3626
Open Access | Times Cited: 1021
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa, et al.
The Lancet (2020) Vol. 396, Iss. 10253, pp. 759-769
Open Access | Times Cited: 799
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 3, pp. 391-412
Open Access | Times Cited: 302
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2023) Vol. 38, Iss. 2, pp. 77-278
Closed Access | Times Cited: 278
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 21, pp. 2649-2660
Open Access | Times Cited: 246
Hypertrophic cardiomyopathy: the future of treatment
C. Vaughan Tuohy, Sanjiv Kaul, Howard K. Song, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 2, pp. 228-240
Open Access | Times Cited: 154
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu, Kam Tong Leung, Ellen Poon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1912-1912
Open Access | Times Cited: 119
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 89
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker, Muhammad Usman, Markus S. Anker, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 936-955
Open Access | Times Cited: 78
Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies
Fnu Sapna, FNU Raveena, Maria Chandio, et al.
Cureus (2023)
Open Access | Times Cited: 58
Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
Alexander Е. Berezin, Alexander A. Berezin
Disease Markers (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 109
Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics
Claudio Napoli, Giuditta Benincasa, Francesco Donatelli, et al.
American Heart Journal (2020) Vol. 224, pp. 113-128
Open Access | Times Cited: 80
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy
Gherardo Finocchiaro, Marco Merlo, Nabeel Sheikh, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 7, pp. 1097-1107
Open Access | Times Cited: 73
Cardiovascular disease burden: Italian and global perspectives
Andrea Saglietto, Roberto Manfredi, Edoardo Elia, et al.
Minerva Cardiology and Angiology (2021) Vol. 69, Iss. 3
Closed Access | Times Cited: 70
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Karen Sliwa, Peter van der Meer, Mark C. Petrie, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 4, pp. 527-540
Open Access | Times Cited: 61
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Craig M. McDonald, Eduardo Marbán, Suzanne Hendrix, et al.
The Lancet (2022) Vol. 399, Iss. 10329, pp. 1049-1058
Open Access | Times Cited: 59
The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report—2022; focus on transplant for restrictive heart disease
Eileen Hsich, Tajinder P. Singh, Wida S. Cherikh, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 10, pp. 1366-1375
Open Access | Times Cited: 50
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
Giovanni Donato Aquaro, Carmelo De Gori, Lorenzo Faggioni, et al.
European Heart Journal Supplements (2023) Vol. 25, Iss. Supplement_C, pp. C130-C136
Open Access | Times Cited: 36
Non‐dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes
Yuko Eda, Takeru Nabeta, Saeko Iikura, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 3, pp. 1463-1471
Open Access | Times Cited: 9
Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction
Qin‐Fen Chen, Jiandong Hu, Jie Hu, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 5, pp. 761-769
Open Access | Times Cited: 8
Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
Seung Hoan Choi, Sean J. Jurgens, Ling Xiao, et al.
Nature Genetics (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top